CapsoVision grants 158,078 stock options to executive

CapsoVision, Inc granted stock options to its Head of Global Sales, Douglas Patrick Atkinson.

Rhea-AI Filing Summary

CapsoVision, Inc granted stock options to its Head of Global Sales, Douglas Patrick Atkinson. He received options to buy 158,078 shares of common stock at an exercise price of $6.90 per share, expiring on June 1, 2036.

The options vest as to 25% of the shares on June 1, 2027, with the remaining 75% vesting in 36 equal monthly installments through June 1, 2030, subject to continued service. Following this award, Atkinson holds a total of 176,847 stock options directly.

Insider Trade Summary

Grant/Award: 158,078 shares

Grant/Award 1 txn

Insider Atkinson Douglas Patrick

Role Head of Global Sales

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	158,078	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 176,847 contracts (Direct)

Footnotes (1)

1. F1. The options vest as to 25% of the shares subject to the option on June 1, 2027 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through June 1, 2030, subject to continued service to the Issuer on each such date.

Key Figures

Options granted: 158,078 options Exercise price: $6.90 per share Expiration date: June 1, 2036 +3 more

6 metrics

Options granted 158,078 options Grant to Head of Global Sales on June 1, 2026

Exercise price $6.90 per share Stock option strike price

Expiration date June 1, 2036 Option term end

Post-grant option holdings 176,847 options Total derivative holdings after transaction

Initial cliff vesting 25% on June 1, 2027 First vesting tranche

Remaining vesting schedule 75% over 36 months Monthly vesting through June 1, 2030

Key Terms

Stock Option (right to buy), exercise price, expiration date, vesting, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

exercise price financial

"conversion_or_exercise_price: 6.9000"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-06-01T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vesting financial

"The options vest as to 25% of the shares subject to the option"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

derivative securities financial

"derivativeTransactionCount: 1"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CapsoVision (CV) report for Douglas Patrick Atkinson?

CapsoVision reported a grant of stock options to Douglas Patrick Atkinson. He received options covering 158,078 shares of common stock, forming part of his compensation as Head of Global Sales, rather than an open-market stock purchase or sale.

What are the key terms of the stock options granted by CapsoVision (CV)?

The options allow purchase of 158,078 CapsoVision common shares at $6.90 per share. They expire on June 1, 2036, giving the executive a long-dated incentive tied to the company’s share price performance over the coming years.

How do the CapsoVision (CV) options granted to Atkinson vest over time?

The options vest 25% on June 1, 2027, with the remaining 75% vesting in 36 equal monthly installments through June 1, 2030. Vesting is conditioned on Atkinson’s continued service with CapsoVision on each vesting date.

How many CapsoVision (CV) stock options does Atkinson hold after this grant?

After the new grant, Atkinson holds 176,847 stock options directly. This total reflects the newly awarded 158,078 options combined with his prior option holdings, as shown in the reported post-transaction balance.

Is the CapsoVision (CV) Form 4 transaction a market buy or sell of shares?

The Form 4 shows a grant of derivative securities, not a market trade. Atkinson received stock options as a grant with a $6.90 exercise price, so no cash stock purchase or sale occurred in the market on the transaction date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 02:14 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Atkinson Douglas Patrick

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Head of Global Sales

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$6.9	06/01/2026		A		158,078		(1)	06/01/2036	Common Stock	158,078	$0	176,847	D

Explanation of Responses:

1. The options vest as to 25% of the shares subject to the option on June 1, 2027 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through June 1, 2030, subject to continued service to the Issuer on each such date.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Douglas Atkinson	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)